TY - JOUR
T1 - Imaging patterns are associated with interstitial lung abnormality progression and mortality
AU - Putman, Rachel K.
AU - Gudmundsson, Gunnar
AU - Axelsson, Gisli Thor
AU - Hida, Tomoyuki
AU - Honda, Osamu
AU - Araki, Tetsuro
AU - Yanagawa, Masahiro
AU - Nishino, Mizuki
AU - Miller, Ezra R.
AU - Eiriksdottir, Gudny
AU - Gudmundsson, Elías F.
AU - Tomiyama, Noriyuki
AU - Honda, Hiroshi
AU - Rosas, Ivan O.
AU - Washko, George R.
AU - Cho, Michael H.
AU - Schwartz, David A.
AU - Gudnason, Vilmundur
AU - Hatabu, Hiroto
AU - Hunninghake, Gary M.
N1 - Funding Information:
Supported by NIH grants K08 HL140087 (R.K.P.); R01 CA203636 (M.N.); U01 HL133232 and R01 HL130974 (I.O.R.); R01 HL116473 and R01 HL122464 (G.R.W.); R01 HL135142, R01 HL113264, and R01 HL137927 (M.H.C.); and P01 HL092870, R01 HL097163, and R33 HL120770 (D.A.S.). Supported by Oddur Olafsson Fund, project grant 141513-051 from the Icelandic Research Fund and Landspitali Scientific Fund A-2015-030 and A-2016-023 (G.G.). The Age, Gene/Environment Susceptibility-Reykjavik Study was supported by NIH contracts N01-AG-1-2100 and HHSN27120120022C, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). NIA grant 27120120022C and project grant 141513-051 from the Icelandic Research Fund (V.G.). G.M.H. and this work were supported by NIH grants R01 HL111024, R01 HL130974, R01 135142, and project grant 141513-051 from the Icelandic Research Fund.
Publisher Copyright:
Copyright © 2019 by the American Thoracic Society
PY - 2019
Y1 - 2019
N2 - Rationale: Interstitial lung abnormalities (ILA) are radiologic abnormalities on chest computed tomography scans that have been associated with an early or mild form of pulmonary fibrosis. Although ILA have been associated with radiologic progression, it is not known if specific imaging patterns are associated with progression or risk of mortality. Objectives: To determine the role of imaging patterns on the risk of death and ILA progression. Methods: ILA (and imaging pattern) were assessed in 5,320 participants from the AGES-Reykjavik Study, and ILA progression was assessed in 3,167 participants. Multivariable logistic regression was used to assess factors associated with ILA progression, and Cox proportional hazards models were used to assess time to mortality. Measurements and Main Results: Over 5 years, 327 (10%) had ILA on at least one computed tomography, and 1,435 (45%) did not have ILA on either computed tomography. Of those with ILA, 238 (73%) had imaging progression, whereas 89 (27%) had stable to improved imaging; increasing age and copies of MUC5B genotype were associated with imaging progression. The definite fibrosis pattern was associated with the highest risk of progression (odds ratio, 8.4; 95% confidence interval, 2.7–25; P = 0.0003). Specific imaging patterns were also associated with an increased risk of death. After adjustment, both a probable usual interstitial pneumonia and usual interstitial pneumonia pattern were associated with an increased risk of death when compared with those indeterminate for usual interstitial pneumonia (hazard ratio, 1.7; 95% confidence interval, 1.2–2.4; P = 0.001; hazard ratio, 3.9; 95% confidence interval, 2.3–6.8; P, 0.0001), respectively. Conclusions: In those with ILA, imaging patterns can be used to help predict who is at the greatest risk of progression and early death.
AB - Rationale: Interstitial lung abnormalities (ILA) are radiologic abnormalities on chest computed tomography scans that have been associated with an early or mild form of pulmonary fibrosis. Although ILA have been associated with radiologic progression, it is not known if specific imaging patterns are associated with progression or risk of mortality. Objectives: To determine the role of imaging patterns on the risk of death and ILA progression. Methods: ILA (and imaging pattern) were assessed in 5,320 participants from the AGES-Reykjavik Study, and ILA progression was assessed in 3,167 participants. Multivariable logistic regression was used to assess factors associated with ILA progression, and Cox proportional hazards models were used to assess time to mortality. Measurements and Main Results: Over 5 years, 327 (10%) had ILA on at least one computed tomography, and 1,435 (45%) did not have ILA on either computed tomography. Of those with ILA, 238 (73%) had imaging progression, whereas 89 (27%) had stable to improved imaging; increasing age and copies of MUC5B genotype were associated with imaging progression. The definite fibrosis pattern was associated with the highest risk of progression (odds ratio, 8.4; 95% confidence interval, 2.7–25; P = 0.0003). Specific imaging patterns were also associated with an increased risk of death. After adjustment, both a probable usual interstitial pneumonia and usual interstitial pneumonia pattern were associated with an increased risk of death when compared with those indeterminate for usual interstitial pneumonia (hazard ratio, 1.7; 95% confidence interval, 1.2–2.4; P = 0.001; hazard ratio, 3.9; 95% confidence interval, 2.3–6.8; P, 0.0001), respectively. Conclusions: In those with ILA, imaging patterns can be used to help predict who is at the greatest risk of progression and early death.
UR - http://www.scopus.com/inward/record.url?scp=85068864854&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068864854&partnerID=8YFLogxK
U2 - 10.1164/rccm.201809-1652OC
DO - 10.1164/rccm.201809-1652OC
M3 - Article
C2 - 30673508
AN - SCOPUS:85068864854
SN - 1073-449X
VL - 200
SP - 175
EP - 183
JO - American Journal of Respiratory and Critical Care Medicine
JF - American Journal of Respiratory and Critical Care Medicine
IS - 2
ER -